NovaBridge Biosciences
(NASDAQ) NBP
NovaBridge Biosciences Financials at a Glance
Market Cap
$304.37M
Revenue (TTM)
$0.00
Net Income (TTM)
$66.40M
EPS (TTM)
$-0.71
P/E Ratio
-3.71
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$2.55
Volume
450,382
Open
$2.53
Price
$2.55
Volume
450,382
Open
$2.53
Previous Close
$2.55
Daily Range
$2.53 - $2.69
52-Week Range
$0.59 - $6.79
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$2.55
Volume
450,382
Open
$2.53
Previous Close
$2.55
Daily Range
$2.53 - $2.69
52-Week Range
$0.59 - $6.79
NBP News
NBP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovaBridge Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
32
CEO
Xi-Yong Fu, PhD, MBA
Website
www.i-mabbiopharma.comHeadquarters
Rockville, MD 20850, US
NBP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-22%
Return on Capital
-5%
Return on Assets
-3%
Earnings Yield
-26.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$304.37M
Shares Outstanding
115.29M
Volume
450.38K
Short Interest
0.00%
Avg. Volume
784.11K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$375.36M
EBITDA
$373.45M
Operating Cash Flow
$52.67M
Capital Expenditure
$48.00K
Free Cash Flow
$52.72M
Cash & ST Invst.
$173.40M
Total Debt
$3.88M
NovaBridge Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.54M
N/A
Gross Margin
0.00%
N/A
Market Cap
$304.37M
N/A
Market Cap/Employee
$9.51M
N/A
Employees
32
N/A
Net Income
$48.68M
-137.6%
EBITDA
$62.46M
-872.6%
Quarterly Fundamentals
Net Cash
$1.60B
+786.9%
Accounts Receivable
$926.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$17.11M
+465.0%
Short Term Debt
$6.21M
+724.4%
Return on Assets
-3.36%
N/A
Return on Invested Capital
-4.82%
N/A
Free Cash Flow
$13.15M
N/A
Operating Cash Flow
$13.15M
N/A